Month: September 2026

Multi-Service Award with a Financial Services Group in Asia Expands Primech’s Integrated Facility Services Portfolio

SINGAPORE, Sept. 17, 2026 (GLOBE NEWSWIRE) — Primech Holdings Limited (Nasdaq: PMEC) (“Primech” or the “Company”), a leading technology-driven facility services provider serving public and private sectors across Singapore, today announced that its subsidiary, Primech A & P Pte. Ltd. (“Primech A & P”), has secured a three-year integrated facility services contract with a financial services group in Asia, valued at approximately S$7.36 million (US$5.78 million).

Contract Details

Under the contract, Primech A & P will provide office cleaning, pest control and waste management services, bringing multiple essential facility requirements under an integrated service delivery model. Services under the contract are expected to commence in the second half of 2026.

The award demonstrates Primech A & P’s ability to deliver multi-service facility solutions for large-scale corporate environments and further expands the Company’s presence in the financial services sector.

The contract value is an estimate based on agreed scope and indicative service volumes, and actual revenue may vary based on usage and scope adjustments.

Advancing Primech’s Integrated Facility Services Model

The contract reflects Primech A & P’s continued expansion of its core cleaning capabilities through a broader integrated facility services model.

By combining office cleaning, pest control and waste management within a single engagement, Primech A & P will coordinate complementary facility services to support the day-to-day operational requirements of the client’s corporate environment.

The multi-service scope builds on Primech A & P’s established cleaning operations while broadening the range of facility services delivered to its customers. This approach enables the Company to address a wider range of operational requirements and deepen its engagement with major commercial and institutional customers.

The award also adds to Primech’s portfolio of multi-year contracts, providing recurring business visibility while supporting the Company’s continued expansion across key commercial sectors.

Management Commentary

“This contract represents an important addition to our commercial portfolio and demonstrates the breadth of services Primech A & P can deliver within a single engagement,” said Ken Ho, Chairman and Chief Executive Officer of Primech Holdings Limited.

“As customers increasingly look for reliable partners that can support multiple aspects of their facility operations, we see opportunities to build on our core cleaning capabilities by delivering a broader range of integrated services. This contract brings together office cleaning, pest control and waste management, demonstrating how we can support more of our customers’ facility requirements through a coordinated service model.”

About Primech Holdings Limited

Primech Holdings Limited (Nasdaq: PMEC) is a Singapore-headquartered, technology-driven facilities services and AI robotics group with operations in Singapore and Hong Kong. Through its subsidiaries, the Group provides cleaning, facilities maintenance, stewarding, waste management and pest control services to public and private sector clients.

Through its subsidiary Primech AI, the Group develops HYTRON, an autonomous restroom-cleaning robot that combines AI perception with robotic manipulation. HYTRON has been commercially deployed in Singapore, with international expansion underway, including a distribution agreement in South Korea and market-entry activities in the United States. The Group also operates HomeHelpy, a digital home-services booking platform serving the consumer market.

Primech Holdings was incorporated in 2020 and listed on the Nasdaq Capital Market in October 2023. For more information, visit investor.primechholdings.com.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements, including, for example, statements about the value, duration, scope, and revenue recognition of the contract described in this announcement, and about anticipated revenues, growth, and expansion. Contract values are estimates based on agreed scope, pricing, and expected service volumes. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. These forward-looking statements are also based on assumptions regarding the Company’s present and future business strategies and the environment in which the Company will operate in the future. Investors can find many (but not all) of these statements by the use of words such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “likely to” or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure that such expectations will be correct. The Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s Annual Report on Form 20-F for the fiscal year ended March 31, 2026, filed with the SEC on July 29, 2026, and its other filings with the SEC.

Investor Relations

Primech Holdings Limited
ir@primechholdings.com
www.primechholdings.com

Opening General Session to Feature Leaders from Host Utility CenterPoint Energy and Pacific Gas & Electric, Duquesne Light Company, San Antonio Water System and Spire Energy

LIBERTY LAKE, Wash., Sept. 17, 2026 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI), the infrastructure provider for modern energy and water management, revealed the speaker lineup for its premier customer-focused event, Itron Inspire 2026. The event will take place in Houston, TX, Oct. 16-21, 2026, with CenterPoint Energy serving as the host utility. More than 1,000 leaders from electric, water, natural gas and smart city organizations will gather to connect with peers and explore practical approaches for addressing the challenges shaping energy and water delivery.

“Every utility is navigating its own set of competing priorities. Demand is growing, infrastructure needs are mounting, workforces are stretched and affordability remains top of mind—all while customer expectations continue to rise,” said Marina Donovan, vice president of global marketing, ESG and public affairs. “These challenges can’t be solved by technology alone. Each year at Itron Inspire, the industry comes together to share what’s working, learn from one another and discuss how utilities can continue to meet the needs of the communities they serve.”

The main event, the Knowledge Conference, takes place Oct. 18-20 and features keynote presentations, breakout sessions and networking events. In the Knowledge Center, attendees can interact with Itron’s integrated solutions and partner offerings through live demonstrations and conversations with product experts. The Itron Experience will also return this year, giving attendees a chance to participate in a virtual game that simulates real-world utility scenarios. Participants will respond to evolving conditions, make trade-off decisions and compete against their peers to achieve the best outcomes.

Keynotes & General Sessions

Opening General Session | Monday, Oct. 19, 8:00-9:30 a.m.

• Ed De Varona, senior vice president of CenterPoint Energy’s electric business, will discuss how the utility is navigating growth, embracing innovation and improving grid resiliency.
• Tom Deitrich, president and CEO of Itron, will highlight the role of data, edge intelligence and AI in helping utilities turn operational insight into action. He’ll also be joined by Mike Delaney, vice president of strategy and innovation at Pacific Gas & Electric (PG&E), for a conversation on how the utility is applying intelligence at the edge to make home electrification easier, reduce operational and maintenance costs and strengthen the utility’s ability to detect and predict grid conditions.
• Marina Donovan, vice president of global marketing, ESG and public affairs, will discuss findings from the 2026 Itron Resourcefulness Report and host a panel discussion with Matthew Llewellyn, director of field operations, customer experience at San Antonio Water System; Brad Anderson, manager, meter reading technologies at Spire; and Mitch Davda, director, meter operations at Duquesne Light Company. Together, they’ll examine how utilities are embracing edge intelligence to optimize operations, improve safety and strengthen reliability and resiliency using infrastructure already in place.

Tuesday General Session | Tuesday, Oct. 20, 8:00-9:30 a.m.

• During the Tuesday General session, Sunny Wescott, Federal Emergency Response Chief Meteorologist and Executive Director for the Geospatial Intelligence Information Sharing and Analysis Center, will discuss how extreme weather is reshaping risk for utilities across the nation.

Big Picture Sessions

• Resiliency Solutions: Planning Smarter, Responding Faster and Operating Safer | Monday, Oct. 19, 2:15-3:15 p.m.: Matt Crye and Danny Petrecca, vice presidents of Resiliency Solutions at Itron, will introduce Itron’s new Resiliency Solutions business unit and its focus on worker safety, damage prevention, emergency preparedness and digital construction management. The session will continue with a discussion moderated by Dr. Michael Webber, energy-water nexus expert and professor at The University of Texas at Austin, featuring Crye and Petrecca as well as Monica Karuturi, executive vice president and general counsel at CenterPoint Energy, and Emeka Igwilo, Chief Data Offer at Southern Company Gas, on how these solutions are being applied in the field.
• Modernize, Don’t Just Replace: Unlocking Grid Edge Value | Tuesday, Oct. 20, 11:15 a.m. -12:00 p.m.: Matt Wakefield, director of information, communication & cyber security at EPRI will moderate a panel with Chris Moris, chief grid architect at PG&E; Robert Trask, principal engineer at Salt River Project; and Akilan Kapilan, director industry advisor at Microsoft, about practical approaches for maximizing existing AMI investments. The group will discuss strategies for modernizing infrastructure, prioritizing high-value applications and turning AMI data into meaningful operational outcomes.

Women Who Inspire | Tuesday, Oct. 20, 3:15-4:15 p.m.

The Women Who Inspire session returns this year in a new format, bringing attendees together for an afternoon tea social and panel discussion featuring women leaders from across the energy and water industries. Katrina Polk, vice president of product management at Itron, will moderate a discussion with Elvimar Rivas, senior analyst at Con Edison; Shelley Parker, vice president at Alectra Utilities; and Latisha Hill, vice president of community affairs and chief customer officer at Avista. Panelists will share insights from their personal and professional journeys, discussing topics such as navigating industry change, embracing innovation and mentorship.

Breakout Sessions

More than 75 customer- and partner-led breakout sessions will take place throughout the conference. Led by utility and industry experts, the sessions are organized across five tracks: Applications, Outcomes and Services; Data Management; Mobile and Measurement Solutions; Multi-Purpose Network Solutions; and Resiliency Solutions. Sessions will showcase how organizations are using intelligence and data-driven strategies to modernize existing infrastructure, respond faster to disruption, manage rising demand and improve outcomes for customers and communities.

Additional Learning Opportunities

Customer forums and working groups, included with a full conference pass, will take place on Sunday, Oct. 18 and Wednesday, Oct. 21, and provide attendees with opportunities to engage directly with product teams, collaborate with industry peers and learn about topics in greater depth. These interactive sessions are designed to foster meaningful dialogue, knowledge sharing and valuable feedback that helps shape the evolution of energy and water solutions. A complete list of sessions can be found here.

Additionally, Itron Inspire features pre-conference product training opportunities from Friday, Oct. 16 to Sunday, Oct. 18 for products including OpenWay^® Collection Manager, Temetra^® and MV-90™ xi. From one-day introductory courses to three-day certified training sessions, the hands-on, expert-led trainings allow utilities to maximize their professional development. For additional information and to register for pre-conference trainings, click here.

For more information about Itron Inspire 2026, visit www.itron.com/inspire. Join the conversation on social media using #ItronInspire26.

About Itron

Itron is transforming how the world manages energy, water and city services. Our trusted intelligent infrastructure solutions help utilities and cities improve efficiency, build resilience and deliver safe, reliable and affordable service. With edge intelligence, we connect people, data insights and devices so communities can better manage the essential resources they rely on to live and thrive. Join us as we create a more resourceful world: www.itron.com.

Itron^®, OpenWay, Temetra, and the Itron Logo are registered trademarks of Itron, Inc. in the United States and other countries and regions. All third-party trademarks are property of their respective owners and any usage herein does not suggest or imply any relationship between Itron and the third party unless expressly stated.

For additional information, contact:

Itron, Inc.

Alison Mallahan
Senior Manager, Corporate Communications
509-891-3802
PR@Itron.com

Paul Vincent
Vice President, Investor Relations
512-560-1172
Investors@itron.com

Itron, Inc.

• LinkedIn: www.linkedin.com/company/itroninc
• X: www.x.com/itroninc
• Newsroom: https://itron.com/newsroom
• Blog: https://itron.com/blog

Dr. Spiegel brings decades of global clinical development, regulatory and oncology leadership experience, including former Chief Medical Officer roles at Schering-Plough and PTC Therapeutics

Appointment further strengthens Ernexa’s Board as the Company advances ERNA-101 toward clinical development

CAMBRIDGE, Mass., Sept. 17, 2026 (GLOBE NEWSWIRE) — Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancers, today announced the appointment of Robert J. Spiegel, M.D., FACP, to its Board of Directors.

Dr. Spiegel is an accomplished physician, biopharmaceutical executive and drug developer with decades of experience spanning oncology, clinical development, regulatory strategy and pharmaceutical leadership. He spent over 25 years at Schering-Plough Research Institute, where he held increasingly senior positions culminating in his role as Chief Medical Officer from 1998 to 2009. He later served as Chief Medical Officer of PTC Therapeutics from 2014 to 2016 and is currently Founder and Principal of Spiegel Consulting LLC and Associate Professor of Medicine at Weill Cornell Medical College.

“We are pleased to welcome Dr. Spiegel to Ernexa’s Board of Directors at an important stage in the Company’s development,” said Sanjeev Luther, President and Chief Executive Officer of Ernexa Therapeutics. “Dr. Spiegel brings an exceptional combination of oncology expertise, clinical development leadership and regulatory experience. His perspective will be highly valuable as we continue advancing ERNA-101 toward clinical evaluation and work to translate our encouraging preclinical findings into a potential new therapeutic option for patients with ovarian cancer and other difficult-to-treat malignancies.”

Dr. James Bristol, Chairman of the Board, added, “Dr. Spiegel’s extensive oncology drug development and regulatory experience will bring valuable perspective to Ernexa’s Board as we prepare ERNA-101 for clinical evaluation. We look forward to working with him as the Company advances its development strategy and builds long-term value for patients and shareholders.”

During his tenure at Schering-Plough, Dr. Spiegel played a significant role in the clinical development and regulatory approval of numerous therapies. His experience included advancing alpha-interferon through Phase 1 to Phase 3 development and FDA approval, developing temozolomide from Phase 1 through worldwide regulatory approval for glioblastoma, and contributing to development programs across oncology, immunology and other therapeutic areas. As Chief Medical Officer, he participated in research governance spanning first-in-human, proof-of-concept and registration-stage development decisions and was involved in more than 30 successful New Drug Applications.

Dr. Spiegel also brings extensive public company board experience, having served on the boards of numerous biotechnology and pharmaceutical companies throughout his career. He currently serves on the boards of Geron Corporation, Ayala Pharmaceuticals, RenovoRx and Sun Pharma Advanced Research Corporation (SPARC).

“I am excited to join Ernexa’s Board of Directors as the Company works to advance its innovative cell therapy platform toward the clinic,” said Dr. Spiegel. “ERNA-101 represents a compelling approach to addressing some of the persistent challenges in ovarian cancer, and I look forward to working with Sanjeev, my fellow Board members and the broader Ernexa team as the Company continues preparing the program for clinical development and explores its potential across oncology.”

Dr. Spiegel earned his M.D. from the University of Pennsylvania and his B.A., cum laude, from Yale University. He completed his medical oncology fellowship at the National Cancer Institute at the National Institutes of Health and currently serves as an Associate Professor of Medicine at Weill Cornell Medical College.

Advancing ERNA-101 Toward Clinical Development

ERNA-101 is Ernexa’s lead cell therapy candidate and is designed to activate and regulate the immune system’s response to recognize and attack cancer cells. The Company’s initial development focus is ovarian cancer, where significant unmet need remains for new therapeutic approaches capable of generating durable responses.

Ernexa’s core technology focuses on engineering induced pluripotent stem cells (iPSCs) and transforming them into induced mesenchymal stem cells (iMSCs). The Company’s allogeneic synthetic iMSCs are designed to provide a scalable, off-the-shelf treatment approach without the need for patient-specific cell harvesting.

Ernexa continues to advance ERNA-101 toward clinical evaluation while executing the manufacturing, regulatory and clinical activities necessary to support its planned transition into a clinical-stage biotechnology company.

About Ernexa Therapeutics

Ernexa Therapeutics (NASDAQ: ERNA) is developing innovative cell therapies for the treatment of advanced cancers. Ernexa’s core technology focuses on engineering induced pluripotent stem cells (iPSCs) and transforming them into induced mesenchymal stem cells (iMSCs). Ernexa’s allogeneic synthetic iMSCs provide a scalable, off-the-shelf treatment solution, without needing patient-specific cell harvesting.

ERNA-101 is the company’s lead cell therapy product, designed to activate and regulate the immune system’s response to recognize and attack cancer cells. The company’s initial focus is to develop ERNA-101 for the treatment of ovarian cancer, with the potential to address multiple difficult-to-treat solid tumors.

For more information, visit www.ernexatx.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements, in some cases, can be identified by terms such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “design,” “intend,” “expect,” “could,” “plan,” “potential,” “predict,” “seek,” “should,” “would,” “contemplate,” “project,” “target,” “objective,” or the negative version of these words and similar expressions. Forward looking statements involve known and unknown risks, uncertainties and other factors that may cause Ernexa’s actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by the forward-looking statements in this press release, including, without limitation, risks and uncertainties related to: progress and possible outcomes of the Company’s lead research project, ERNA-101, and future research projects. Forward-looking statements are based upon Ernexa’s current expectations and involve assumptions that may never materialize or may prove to be incorrect. All forward-looking statements are expressly qualified in their entirety by these cautionary statements. For a detailed description of Ernexa’s risks and uncertainties, you are encouraged to review its documents filed with the SEC including its recent filings on Form 8-K, Form 10-K and Form 10-Q. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. Ernexa does not undertake any obligation to update the forward-looking statements contained herein to reflect events that occur or circumstances that exist after the date here of, except as required by applicable law.

Media Contact
Sharon Golubchik
RAYNZ
sharon@raynzhealth.com

Investor Contact
Jenene Thomas
JTC Team, LLC
(908) 824-0775
ERNA@jtcir.com